LATEST
Silgan / Trivium: minority stakenewBF International Best Fields Best Food / DiagramnewOpenWorld agreed to acquire Blocksight HoldingsnewMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
Agreement signedPublished 16 Jul 2024

OMERS /
Aclaris Therapeutics, Inc.

OMERS agrees to buy Aclaris Therapeutics, Inc.

Buy side: OMERS
Buy sideOMERS
Target: Aclaris Therapeutics, Inc.
TargetAclaris Therapeutics, Inc.
Source · 16 Jul 2024Source-verified
See the source
Buy side: OMERS
Buy sideOMERS
Target: Aclaris Therapeutics, Inc.
TargetAclaris Therapeutics, Inc.
01 / BuyerOMERS
02 / TargetAclaris Therapeutics, Inc.
Source-verified
01

What happened

OMERS agreed to acquire Aclaris Therapeutics, Inc., according to a filing dated July 16, 2024.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

OMERS agrees to buy Aclaris Therapeutics, Inc.

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.